Osaic Holdings’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Osaic Holdings’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,386	Closed	-$596	–	7693
2024 Q2	$596	Sell	2,386 -5,250	-69%	-$1.95K	﹤0.01%	6939
2024 Q1	$5.48K	Hold	7,636	–	–	﹤0.01%	6040
2023 Q4	$6.49K	Hold	7,636	–	–	﹤0.01%	6048
2023 Q3	$10.5K	Hold	7,636	–	–	﹤0.01%	5893
2023 Q2	$19.2K	Hold	7,636	–	–	﹤0.01%	5588
2023 Q1	$17.3K	Buy	7,636 +1,500	+24%	+$3.8K	﹤0.01%	5653
2022 Q4	$8K	Buy	6,136 +2,500	+69%	+$4.2K	﹤0.01%	6080
2022 Q3	$7K	Hold	3,636	–	–	﹤0.01%	6234
2022 Q2	$6K	Buy	+3,636	New	+$13.7K	﹤0.01%	6431

Osaic Holdings's VAXX Position: Q3 2024 in Review

Osaic Holdings sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 2,386 shares — an estimated $596 sold.

Osaic Holdings first reported a position in VAXX in Q2 2022 and held it in 9 quarters. The position peaked at $19.2K in Q2 2023. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

Osaic Holdings reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
Osaic Holdings sold 2,386 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $596.
Osaic Holdings first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 9 quarters.
Osaic Holdings's Vaxxinity, Inc. Class A Common Stock position peaked at $19.2K in Q2 2023.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.